MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    SETTING UP A PEDIATRIC DEEP BRAIN STIMULATION UNIT

    J. Ferrero-Turrión, A. Salazar-Villacorta, A. Bescos, G. Español, L. Ispierto, R. Alvarez, M. Tardáguila, J. Muñoz, L. Ventura-Expósito, B. Pérez-Dueñas (Barcelona, Spain)

    Objective: Describe our 2-year experience establishing a pediatric deep brain stimulation (pDBS) service in a tertiary hospital and report our outcomes. Background: DBS is a…
  • 2022 International Congress

    Comparison of Voice, Speech, Swallowing and Drooling Problems in Parkinson’s Disease Patients with Healthy Individuals

    M. Sapmaz Atalar, G. Genç, ş. Oğur (Istanbul, Turkey)

    Objective: To compare voice, speech, swallowing and drooling problems in Parkinson's disease (PD) patients with healthy individuals (HI) by using objective and subjective methods and…
  • 2022 International Congress

    The profile of dysautonomia in the early stages of Parkinson’s disease and multiple system atrophy: the importance of using the SCOPA-AUT scale

    M. Jecmenica-Lukic, I. Stankovic, A. Tomic, N. Kresojevic, V. Markovic, I. Petrovic, N. Dragasevic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To examine the profile of autonomic dysfunction and the utility of the SCOPA-AUT scale in distinguishing patients with early Parkinson's disease (PD) and MSA-parkinsonism (MSA-P)…
  • 2022 International Congress

    Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

    Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    A Mixed Methods Study on the Impact of Reading the Graphic Memoir My Degeneration: A Journey Through Parkinson’s on Patients with Parkinson’s Disease

    M. Green, S. de Jesus, D. George, L. van Scoy, K. Myers (Hershey, USA)

    Objective: To explore the impact of reading a graphic memoir on patients’ knowledge, mental health, and attitudes about living with Parkinson Disease (PD). Background: In…
  • 2022 International Congress

    Pallidal beta activity correlates with stimulation-induced bradykinesia in dystonia patients

    R. Lofredi, U. Scheller, A. Mindermann, J. Krauss, A. Saryyeva, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: Identify a neurophysiological correlate of stimulation-induced bradykinesia in dystonia Background: Bradykinesia is a known side-effect of pallidal deep brain stimulation (DBS) in dystonia patients…
  • 2022 International Congress

    Metabolic profile in the brain with Fragile X-associated Tremor/Ataxia Syndrome (FXTAS)

    M. Salcedo-Arellano, M. Johnson, Y. Hwang, Y. Mclennan, E. Mcbride, P. Juarez, B. Durbin-Johnson, F. Tassone, R. Hagerman, V. Martinez-Cerdeno (Sacramento, USA)

    Objective: We analyzed changes in the concentration of primary metabolites in post-mortem brain samples from FXTAS cases. We also investigated how these changes relate to…
  • 2022 International Congress

    Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy

    H. Sarac, F. Borovecki, I. Sarac, N. Henigsberg (Zagreb, Croatia)

    Objective: to demonstrate association between the tardive dyskinesia and methotrexate therapy. Background: Dystonia is found among patients taking methotrexate. However, methotrexate and tardive oro-bucco-lingual dyskinesia…
  • 2022 International Congress

    Automatic Speech Recognition for speech therapy in a Parkinson’s disease patient

    A. Nuzzi (Bari, Italy)

    Objective: The aim of the present study was to examine the Automatic Speech Recognition (ASR) technology as a useful approach to enhance the speech intelligibility…
  • 2022 International Congress

    Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

    C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

    Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
  • « Previous Page
  • 1
  • …
  • 419
  • 420
  • 421
  • 422
  • 423
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley